Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × 16-fluoroestradiol × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1

Interventions

Paclitaxel 12 pembrolizumab 8 Carboplatin 7 Surveys and Questionnaires 6 Cisplatin 5 Doxorubicin 4 Docetaxel 4 Brachytherapy 4 Gemcitabine 3 FANG vaccine 3 olaparib 2 durvalumab 2 Topotecan 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Oxaliplatin 2 Music Therapy 2 Mitomycin 2 Leucovorin 2 Letrozole 2 Imagery, Psychotherapy 2 Hysterectomy 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorouracil 2 Exercise 2 CP protocol 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05916196 2025-05-08

[18F]FES PET/.CT in Uterine Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡